Ignite Creation Date:
2024-05-19 @ 5:34 PM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06415344
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
2024-05-16
First Post:
2024-05-10
Brief Title:
Long-term Extension of GTX-102 in Angelman Syndrome
Sponsor:
Ultragenyx Pharmaceutical Inc
Organization:
Ultragenyx Pharmaceutical Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Angelman Syndrome |
Keywords: